ANI Pharmaceuticals, Inc. (ANIP)

USD 53.88

(-3.49%)

Market Cap (In USD)

1.13 Billion

Revenue (In USD)

486.81 Million

Net Income (In USD)

18.77 Million

Avg. Volume

352.77 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
52.0-70.81
PE
-
EPS
-
Beta Value
0.71
ISIN
US00182C1036
CUSIP
00182C103
CIK
1023024
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Nikhil Lalwani
Employee Count
-
Website
https://www.anipharmaceuticals.com
Ipo Date
2000-05-05
Details
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

More Stocks